Convergence Investment Partners, LLC
Position in BIIB — Biogen Inc.
CIK 1456133
PALM BEACH GARDENS, FL
Position in BIIB
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$5,038,735
+$2,553,331 QoQ
Shares Held
23,321
+72.0% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.49%
of 13F equity value
Holder Rank
#245
of 1,036 holders
Holding Since
Mar 2020
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Convergence Investment Partners, LLC holds $41,023,211 across 9 Drug Manufacturers - General names. BIIB ranks #4 (12.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
170,194 | $9,806,578 | |
| 2 | MRK |
Merck & Co., Inc.
|
68,437 | $8,794,154 | |
| 3 | JNJ |
Johnson & Johnson
|
29,971 | $7,611,734 | |
| 4 | BIIB |
Biogen Inc.
This page
|
23,321 | $5,038,735 | |
| 5 | ABBV |
AbbVie Inc.
|
19,281 | $4,851,870 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
29,203 | $3,689,507 | |
| 7 | LLY |
ELI LILLY & Co
|
592 | $710,062 | |
| 8 | AMGN |
Amgen Inc
|
770 | $278,832 |
All Filings in BIIB
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,038,735 | 23,321 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $2,485,404 | 13,557 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $2,139,334 | 12,156 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $1,342,386 | 9,583 | Shares | Sole | 2025-11-04 | |
| 2020-09-30 | $1,168,194 | 4,118 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $1,095,082 | 4,093 | Shares | Sole | 2020-07-30 | |
| 2020-03-31 | $971,602 | 3,071 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||